Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AMG 890 in Subjects With Elevated Plasma Lipoprotein(a) [Phase 1]

View source ↗

Summary

Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamics study of AMG 890 in adults with elevated lipoprotein(a) and cardiovascular disease; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• AMG 890

Snippet

Sponsor: Amgen | Conditions: Cardiovascular Disease | Phase 1 | Status: COMPLETED | Results posted: 2026-01-28